Ragonnaud E - Search Results

1

Therapeutic B-cell depletion reverses progression of Alzheimer's disease.

Kim K, Wang X, Ragonnaud E, Bodogai M, Illouz T, DeLuca M, McDevitt RA, Gusev F, Okun E, Rogaev E, Biragyn A. Kim K, et al. Among authors: ragonnaud e. Nat Commun. 2021 Apr 12;12(1):2185. doi: 10.1038/s41467-021-22479-4. Nat Commun. 2021. PMID: 33846335 Free PMC article.

2

Cancer co-opts differentiation of B-cell precursors into macrophage-like cells.

Chen C, Park B, Ragonnaud E, Bodogai M, Wang X, Zong L, Lee JM, Beerman I, Biragyn A. Chen C, et al. Among authors: ragonnaud e. Nat Commun. 2022 Sep 14;13(1):5376. doi: 10.1038/s41467-022-33117-y. Nat Commun. 2022. PMID: 36104343 Free PMC article.

3

Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis.

Ragonnaud E, Moritoh K, Bodogai M, Gusev F, Garaud S, Chen C, Wang X, Baljinnyam T, Becker KG, Maul RW, Willard-Gallo K, Rogaev E, Biragyn A. Ragonnaud E, et al. Cancer Res. 2019 Nov 15;79(22):5826-5838. doi: 10.1158/0008-5472.CAN-19-1058. Epub 2019 Oct 1. Cancer Res. 2019. PMID: 31575547 Free PMC article.

4

Gut microbiota as the key controllers of "healthy" aging of elderly people.

Ragonnaud E, Biragyn A. Ragonnaud E, et al. Immun Ageing. 2021 Jan 5;18(1):2. doi: 10.1186/s12979-020-00213-w. Immun Ageing. 2021. PMID: 33397404 Free PMC article. Review.

5

Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition.

Pomatto-Watson LCD, Bodogai M, Bosompra O, Kato J, Wong S, Carpenter M, Duregon E, Chowdhury D, Krishna P, Ng S, Ragonnaud E, Salgado R, Gonzalez Ericsson P, Diaz-Ruiz A, Bernier M, Price NL, Biragyn A, Longo VD, de Cabo R. Pomatto-Watson LCD, et al. Among authors: ragonnaud e. Nat Commun. 2021 Oct 27;12(1):6201. doi: 10.1038/s41467-021-26431-4. Nat Commun. 2021. PMID: 34707136 Free PMC article.

6

Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.

Ragonnaud E, Andersson AC, Mariya S, Pedersen AG, Burk RD, Folgori A, Colloca S, Cortese R, Nicosia A, Pamungkas J, Iskandriati D, Holst PJ. Ragonnaud E, et al. J Immunother. 2017 Feb/Mar;40(2):51-61. doi: 10.1097/CJI.0000000000000153. J Immunother. 2017. PMID: 28166180

7

CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine γ-herpesvirus 68 infection.

Boilesen DR, Ragonnaud E, Laursen H, Andersson AC, Tolver A, Spiess K, Holst PJ. Boilesen DR, et al. Among authors: ragonnaud e. Vaccine. 2019 May 16;37(22):2952-2959. doi: 10.1016/j.vaccine.2019.04.034. Epub 2019 Apr 18. Vaccine. 2019. PMID: 31006497

8

Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.

Holst PJ, Jensen BA, Ragonnaud E, Thomsen AR, Christensen JP. Holst PJ, et al. Among authors: ragonnaud e. PLoS One. 2015 Feb 13;10(2):e0117242. doi: 10.1371/journal.pone.0117242. eCollection 2015. PLoS One. 2015. PMID: 25679375 Free PMC article.

9

An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.

Ragonnaud E, Andersson AM, Pedersen AE, Laursen H, Holst PJ. Ragonnaud E, et al. Vaccine. 2016 Apr 19;34(18):2147-56. doi: 10.1016/j.vaccine.2015.06.087. Epub 2016 Mar 19. Vaccine. 2016. PMID: 27004934

10

Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens.

Ragonnaud E, Pedersen AG, Holst PJ. Ragonnaud E, et al. Scand J Immunol. 2017 Mar;85(3):182-190. doi: 10.1111/sji.12522. Scand J Immunol. 2017. PMID: 28109028 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page